As part of its ambitious regional growth strategy, DEVARTLab is proud to announce its new strategic partnership with Muscat Pharmacy, one of the most established and trusted pharmaceutical distribution companies in the Sultanate of Oman.
This collaboration marks a significant step in DEVARTLab’s
expansion across the GCC, with the introduction of its flagship
products—Hyalolite and Exotropin—to the Omani market. Both products are already
recognized for their quality and scientific innovation across multiple regional
markets.
This strategic move is designed to strengthen DEVARTLab’s footprint in Oman by leveraging Muscat Pharmacy’s extensive distribution network, regulatory expertise, and strong ties with healthcare providers.
Muscat Pharmacy has long been regarded as a pillar of
pharmaceutical excellence in Oman, with a legacy of commitment to quality,
service, and innovation. DEVARTLab is honored to partner with such a
prestigious organization and looks forward to a fruitful collaboration that
brings meaningful health solutions to patients across the Sultanate.
This partnership exemplifies DEVARTLab’s mission to build
regional alliances rooted in trust, mutual growth, and delivering advanced
healthcare innovations to every market it serves.